controloc 20 mg zarnās šķīstošās tabletes
takeda gmbh, germany - pantoprazols - zarnās šķīstošā tablete - 20 mg
controloc 20 20 mg zarnās šķīstošās tabletes
takeda pharma sp.z o.o., poland - pantoprazols - zarnās šķīstošā tablete - 20 mg
pantul 40 mg zarnās šķīstošās tabletes
g.l. pharma gmbh, austria - pantoprazols - zarnās šķīstošā tablete - 40 mg
pantul 20 mg zarnās šķīstošās tabletes
g.l. pharma gmbh, austria - pantoprazols - zarnās šķīstošā tablete - 20 mg
vydura
pfizer europe ma eeig - rimegepant - migrēnas traucējumi - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
aquipta
abbvie deutschland gmbh & co. kg - atogepant - migrēnas traucējumi - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
controloc 40 mg zarnās šķīstošās tabletes
takeda gmbh, germany - pantoprazols - zarnās šķīstošā tablete - 40 mg
ceprotin
takeda manufacturing austria ag - cilvēka olbaltumviela c. - purpura fulminans; protein c deficiency - antitrombotiskie līdzekļi - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.